Prevention of aortic calcification by etidronate in the renal failure rat model
Authors:
- Yusuke SuzukiYSYusuke Suzuki
- Mayumi MatsushitaMMMayumi Matsushita
- Hiroyuki FujiiHFHiroyuki Fujii
- Chisato MiyauraCMChisato Miyaura
- Sumio AizawaSASumio Aizawa
- Hiroshi KogoHKHiroshi Kogo
- 1 March 2007
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 558 (1-3) , 159-166
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Inhibition of the Progression of Aortic Calcification by Etidronate Treatment in Hemodialysis Patients: Long‐Term EffectsTherapeutic Apheresis and Dialysis, 2006
- Bone Morphogenetic Proteins in Vascular CalcificationCirculation Research, 2005
- Vascular CalcificationArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Inhibitory Effects of Etidronate on the Progression of Vascular Calcification in Hemodialysis PatientsTherapeutic Apheresis and Dialysis, 2004
- In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3Nephrology Dialysis Transplantation, 2003
- Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Pathophysiological mechanisms of vascular calcification in end-stage renal diseaseKidney International, 2001
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Osteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal WomenCalcified Tissue International, 1998
- BisphosphonatesDrugs, 1991